Stock markets likely to rally up to 15% in 3-6 Months; Check top picks by Nuvama’s Manav Chopra - Markets

Stock markets likely to rally up to 15% in 3-6 Months; Check top picks by Nuvama’s Manav Chopra – Markets

Among themes, infrastructure-led capital expenditure remains his strongest conviction. “I’m very constructive on infra-capex as a theme. This is where the broader market could see larger alpha movers,” Chopra said. Within the space, he highlighted Adani group companies as potential leaders. “Adani Energy Solutions, Adani Power, and from the large caps, Adani Ports — this…

Read More
These stocks reporting next week have a history of earnings beats and share gains

These stocks reporting next week have a history of earnings beats and share gains

Morgan Stanley and Citizens Financial often beat earnings and see shares rise, with recent analyst upgrades signalling potential upside ahead of next weeks reports. As earnings season kicks off in earnest next week, companies like Morgan Stanley and Citizens Financial Group could exceed Wall Street’s expectations and see their shares climb as a result. Continue…

Read More
Top Gainers and Losers Today, 10 April 2026: Wipro Ltd, Shriram Finance Ltd lead gains; Bajaj Auto Ltd, Sun Pharmaceutical Industries Ltd among top losers - Markets

Top Gainers and Losers Today, 10 April 2026: Wipro Ltd, Shriram Finance Ltd lead gains; Bajaj Auto Ltd, Sun Pharmaceutical Industries Ltd among top losers – Markets

Get real-time updates on the top gainers and losers across NSE Nifty. Track rising stocks, declining trends, price movements, and sector-wise performance. Stay ahead in the market with key insights from ET Now. Here is the list of stocks that are the Top gainers and Losers stocks during the trading session today – Top-performing stocks…

Read More
Investment Strategy at 50: Lump Sum or SIP? 9 funds recommended by expert to plan smart and balance risk - Mutual Funds

Weight-loss drug price war erupts! Amid sales decline, can Mounjaro hold ground as cheaper rivals flood market? – Markets

Written by: Heena Ojha Updated Apr 10, 2026 12:43 IST The expiry of Novo Nordisk’s semaglutide patent has opened the door for generic manufacturers in the Indian market. (Image: iStock/ ET Now Digital) No stock data available Weight loss drug mounjaro: Sales of Eli Lilly’s Mounjaro eased in March as intensifying price competition in the…

Read More
Top Gainers and Losers Today, 10 April 2026: Wipro Ltd, Shriram Finance Ltd lead gains; Bajaj Auto Ltd, Sun Pharmaceutical Industries Ltd among top losers - Markets

Top Gainers and Losers Today, 10 April 2026: Wipro Ltd, Shriram Finance Ltd lead gains; Bajaj Auto Ltd, Sun Pharmaceutical Industries Ltd among top losers – Markets

Get real-time updates on the top gainers and losers across NSE Nifty. Track rising stocks, declining trends, price movements, and sector-wise performance. Stay ahead in the market with key insights from ET Now. Here is the list of stocks that are the Top gainers and Losers stocks during the trading session today – Top-performing stocks…

Read More
Titan share price surge as Morgan Stanley raises target price by nearly 13% on jewellery strength - Markets

Titan share price surge as Morgan Stanley raises target price by nearly 13% on jewellery strength – Markets

Titan Company Ltd.’s share price rose 0.47 per cent on Friday after Morgan Stanley revised its target price upward by nearly 13 per cent to Rs 5,102 from Rs 4,529, citing stronger-than-expected performance in the jewellery segment. The brokerage maintained its ‘Overweight’ rating, upgrading revenue and earnings estimates over the medium term on sustained domestic…

Read More
TCS Share Price Target, Q4FY26 Review: Deal wins support outlook, brokerages flag slow growth, margin discipline - Markets

TCS Share Price Target, Q4FY26 Review: Deal wins support outlook, brokerages flag slow growth, margin discipline – Markets

Tata Consultancy Services’ March-quarter performance has drawn a largely balanced response from brokerages, with strong deal wins and steady margins offset by lingering concerns around revenue momentum and macro uncertainty. While analysts remain constructive on TCS’ long-term positioning and AI-led opportunities, most have trimmed target prices to reflect slower growth expectations for FY27 and beyond,…

Read More